The Asia-Pacific dipeptidyl peptidase 4 (DPP-4) inhibitors market is anticipated to grow significantly at a CAGR of 3.5% over the forecast period (2020-2026). China, India, Japan, ASEAN, South Korea, and the Rest of Asia-Pacific are the major countries contributing to the growth of the Asia-Pacific dipeptidyl peptidase 4 (DPP-4) inhibitors industry over the forecast period. […]
